Sai Parenteral's Initial Public Offering Scheduled for March 24 with a Price Band of ₹372-392 Per Share

Sai Parenteral's Initial Public Offering (IPO) Details

IPO Price Band The IPO price band for Sai Parenteral has been fixed between ₹372 to ₹392 per equity share of the face value of ₹5.

IPO Subscription Schedule The IPO subscription is scheduled to take place from Tuesday, March 24 to Friday, March 27. Monday, March 23 has been allocated for anchor investors.

IPO Allocation The IPO has reserved:

Read also: SMR Jewels IPO Successfully Lists with Institutional Support

• Not more than 50% of the shares for qualified institutional buyers (QIB)
• Not less than 15% for non-institutional institutional investors (NII)
• Not less than 35% of the offer for retail investors

IPO Basis of Allotment The basis of allotment of shares is expected to be finalised on Monday, March 30.

IPO Listing The shares are expected to be listed on BSE and NSE on Thursday, April 2.

IPO Details The IPO is expected to generate ₹408.79 crore, including:

Read also: Zepto Nears $1 Billion Quarterly Net Order Value Milestone Before IPO

• Fresh shares valued at ₹285 crore
• An offer for sale (OFS) amounting to ₹123.79 crore

Funds Utilization The funds raised from the new share issue will be allocated for:

• Expanding capacity and enhancing manufacturing facilities
• Establishing a new research and development center
• Repaying debts
• Meeting working capital needs
• Addressing general corporate expenses

Issue Details The IPO is being managed by Arihant Capital Markets, with Bigshare Services serving as the registrar for the offering.

Company Overview Sai Parenteral operates within the pharmaceutical formulations sector, specializing in research, development, and manufacturing. The company focuses on branded generic formulations and offers products and services as a contract development and manufacturing organization (CDMO). Its product range spans various therapeutic areas.

Financial Performance For the half-year period ending September 30, 2025, Sai Parenteral recorded a net profit of ₹7.76 crore and a revenue of ₹89.43 crore. For the fiscal year 2024-25, the company posted a bottom line of ₹14.43 crore and a revenue of ₹163.74 crore. The company's market capitalization currently exceeds ₹1,730 crore.